Comparison of the effects of sitagliptin and dapagliflozin on Adiponectin and Lipid Profile

Abstract

Type 2 diabetes mellitus (T2DM) is an acquired form of diabetes often associated with being overweight and having an unhealthy lifestyle with respect to diet and exercise. It also shows a stronger association of onset with increasing age and is more common in certain ethnic groups such as South Asian and Afro-caribbeans. Although SGLT2 inhibitors have become an early recommended drug for patients with type 2 diabetes at a high risk of cardiovascular events, its effectiveness as a first-line medication for patients with newly diagnosed type 2 diabetes with no history of cardiovascular events is unclear